Generic drugs in Singapore are registered through the Health Sciences Authority (HSA). Applicants must submit a dossier demonstrating bioequivalence to the reference product, ensuring safety, efficacy, and quality. The HSA reviews the application, and upon approval, the generic drug is listed in the Singapore Register of Therapeutic Products for market authorization.
